Contract Details: 6D02403933
Contract
Vendor Name:
EMERGENT BIOSOLUTIONS
Description:
Pharmaceutical and other medicinal products
Economic Object Code:
1132
Instrument Type:
Amendment
Commodity Type:
Good
Commodity Code:
N6505
Organization:
Public Health Agency of Canada
Vendor Postal Code:
R3T
Comments:
Pharmaceutical and Other Medicinal Products
Additional Comments:
Drugs and Biologicals
Buyer Name:
NA
Date and Value
Reporting Period:
2022-2023-Q1
Contract Date:
Mar 19, 2021
Contract Period Start Date:
Mar 19, 2021
Contract Period End or Delivery Date:
Mar 31, 2024
Total Contract Value:
$11,767,050.34
Original Contract Value:
$150,171.22
Amendment Value:
$11,616,879.12
Applicable Trade Agreements
| Canadian Free Trade Agreement |
| Canada-Chile Free Trade Agreement |
| Canada-Colombia Free Trade Agreement |
| Comprehensive Economic Free Trade Agreement |
| World Trade Organization – Agreement on Government Procurement |
| Canada-Honduras Free Trade Agreement |
| Canada-Korea Free Trade Agreement |
| Canada-Panama Free Trade Agreement |
| Canada-Peru Free Trade Agreement |
| Comprehensive and Progressive Agreement for Trans-Pacific Partnership |
| Canada-Ukraine Free Trade Agreement |
Additional Details
Procurement Identification Number:
6D02403933
Solicitation Procedure:
Non-Competitive
Limited Tendering Reason:
Prototype Purchase
Trade Agreement Exceptions and Exclusions:
None
Comprehensive Land Claims Agreement:
Not Applicable
Procurement Strategy for Indigenous Business:
1. None
Indigenous Business excluding PSIB:
No
Intellectual Property:
No IP Terms in Contract
Potential Commercial Exploitation:
No
Former Public Servant:
No
Ministers Office Contracts:
No
Country of Vendor:
Canada
Number of Bids:
1
Article 6 Government Contract Exceptions:
Only one person is capable of performing the contract
Award Criteria:
Not applicable
Socio-Economic Indicator:
None